The major histocompatibility complex (MHC) restriction element for a human Ni2+ reactive T cell, ANi-2.3, was identified as DR52c. A series of experiments established that the functional ligand for this T cell was a preformed complex of Ni2+ bound to the combination of DR52c and a specific peptide that was generated in human and mouse B cells, but not in fibroblasts nor other antigen processing–deficient cells. In addition, ANi-2.3 recognition of this complex was dependent on His81 of the MHC β chain, suggesting a role for this amino acid in Ni2+ binding to MHC. We propose a general model for Ni2+ recognition in which βHis81 and two amino acids from the NH2-terminal part of the MHC bound peptide coordinate Ni2+ which then interacts with some portion of the Vα CDR1 or CDR2 region.
Skip Nav Destination
Article navigation
3 March 2003
Article|
March 03 2003
Components of the Ligand for a Ni++ Reactive Human T Cell Clone
Linh Lu,
Linh Lu
1Howard Hughes Medical Institute, Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
Jörg Vollmer,
Jörg Vollmer
2Max-Planck-Institute für Immunbiologie, Stübeweg 51, 79108 Freiburg, Germany
Search for other works by this author on:
Corinne Moulon,
Corinne Moulon
2Max-Planck-Institute für Immunbiologie, Stübeweg 51, 79108 Freiburg, Germany
Search for other works by this author on:
Hans Ulrich Weltzien,
Hans Ulrich Weltzien
2Max-Planck-Institute für Immunbiologie, Stübeweg 51, 79108 Freiburg, Germany
Search for other works by this author on:
Philippa Marrack,
Philippa Marrack
1Howard Hughes Medical Institute, Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
3Department of Biochemistry and Molecular Genetics, University of Colorado Health Science Center, Denver, CO 80262
Search for other works by this author on:
John Kappler
John Kappler
1Howard Hughes Medical Institute, Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
4Department of Pharmacology and Program in Biomolecular Structure, University of Colorado Health Science Center, Denver, CO 80262
Search for other works by this author on:
Linh Lu
1Howard Hughes Medical Institute, Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Jörg Vollmer
2Max-Planck-Institute für Immunbiologie, Stübeweg 51, 79108 Freiburg, Germany
Corinne Moulon
2Max-Planck-Institute für Immunbiologie, Stübeweg 51, 79108 Freiburg, Germany
Hans Ulrich Weltzien
2Max-Planck-Institute für Immunbiologie, Stübeweg 51, 79108 Freiburg, Germany
Philippa Marrack
1Howard Hughes Medical Institute, Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
3Department of Biochemistry and Molecular Genetics, University of Colorado Health Science Center, Denver, CO 80262
John Kappler
1Howard Hughes Medical Institute, Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
4Department of Pharmacology and Program in Biomolecular Structure, University of Colorado Health Science Center, Denver, CO 80262
Address correspondence to John Kappler, Howard Hughes Medical Institute, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206. Phone: 303-398-1322; Fax: 303-398-1396; E-mail: [email protected]
Jörg Vollmer's present address is Coley Pharmaceutical GmbH, Elisabeth-Selbert-Str. 9, D-40764 Langenfeld, Germany.
Corinne Moulon's present address is Dictagene, Chemin de la Vuiliette 4, 1000 Lausanne 25, Switzerland.
*
Abbreviations used in this paper: BSS, balanced salt solution; GFP, green fluorescent protein; SEB, staphylococcal enterotoxin B.
Received:
October 04 2002
Revision Received:
November 15 2002
Accepted:
December 17 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 197 (5): 567–574.
Article history
Received:
October 04 2002
Revision Received:
November 15 2002
Accepted:
December 17 2002
Citation
Linh Lu, Jörg Vollmer, Corinne Moulon, Hans Ulrich Weltzien, Philippa Marrack, John Kappler; Components of the Ligand for a Ni++ Reactive Human T Cell Clone . J Exp Med 3 March 2003; 197 (5): 567–574. doi: https://doi.org/10.1084/jem.20021762
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement